Cargando…

Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease

BACKGROUND: Among subjects with exercise intolerance and suspected early‐stage pulmonary hypertension (PH), early identification of pulmonary vascular disease (PVD) with noninvasive methods is essential for prompt PH management. HYPOTHESIS: Rest gas exchange parameters (minute ventilation to carbon...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Farhan, Dharmavaram, Naga, Hess, Timothy, Dhingra, Ravi, Runo, James, Chybowski, Amy, Kozitza, Callyn, Batra, Supria, Horn, Evelyn M., Chesler, Naomi, Eldridge, Marlowe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286332/
https://www.ncbi.nlm.nih.gov/pubmed/35419844
http://dx.doi.org/10.1002/clc.23831
_version_ 1784747986606096384
author Raza, Farhan
Dharmavaram, Naga
Hess, Timothy
Dhingra, Ravi
Runo, James
Chybowski, Amy
Kozitza, Callyn
Batra, Supria
Horn, Evelyn M.
Chesler, Naomi
Eldridge, Marlowe
author_facet Raza, Farhan
Dharmavaram, Naga
Hess, Timothy
Dhingra, Ravi
Runo, James
Chybowski, Amy
Kozitza, Callyn
Batra, Supria
Horn, Evelyn M.
Chesler, Naomi
Eldridge, Marlowe
author_sort Raza, Farhan
collection PubMed
description BACKGROUND: Among subjects with exercise intolerance and suspected early‐stage pulmonary hypertension (PH), early identification of pulmonary vascular disease (PVD) with noninvasive methods is essential for prompt PH management. HYPOTHESIS: Rest gas exchange parameters (minute ventilation to carbon dioxide production ratio: V (E)/VCO(2) and end‐tidal carbon dioxide: ETCO(2)) can identify PVD in early‐stage PH. METHODS: We conducted a retrospective review of 55 subjects with early‐stage PH (per echocardiogram), undergoing invasive exercise hemodynamics with cardiopulmonary exercise test to distinguish exercise intolerance mechanisms. Based on the rest and exercise hemodynamics, three distinct phenotypes were defined: (1) PVD, (2) pulmonary venous hypertension, and (3) noncardiac dyspnea (no rest or exercise PH). For all tests, *p < .05 was considered statistically significant. RESULTS: The mean age was 63.3 ± 13.4 years (53% female). In the overall cohort, higher rest V (E)/VCO(2) and lower rest ETCO(2) (mm Hg) correlated with high rest and exercise pulmonary vascular resistance (PVR) (r ~ 0.5–0.6*). On receiver‐operating characteristic analysis to predict PVD (vs. non‐PVD) subjects with noninvasive metrics, area under the curve for pulmonary artery systolic pressure (echocardiogram) = 0.53, rest V (E)/VCO(2) = 0.70* and ETCO(2) = 0.73*. Based on this, optimal thresholds of rest V (E)/VCO(2) > 40 mm Hg and rest ETCO(2) < 30 mm Hg were applied to the overall cohort. Subjects with both abnormal gas exchange parameters (n = 12, vs. both normal parameters, n = 19) had an exercise PVR 5.2 ± 2.6* (vs. 1.9 ± 1.2), mPAP/CO slope with exercise 10.2 ± 6.0* (vs. 2.9 ± 2.0), and none included subjects from the noncardiac dyspnea group. CONCLUSIONS: In a broad cohort of subjects with suspected early‐stage PH, referred for invasive exercise testing to distinguish mechanisms of exercise intolerance, rest gas exchange parameters (V (E)/VCO(2) > 40 mm Hg and ETCO(2) < 30 mm Hg) identify PVD.
format Online
Article
Text
id pubmed-9286332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92863322022-07-19 Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease Raza, Farhan Dharmavaram, Naga Hess, Timothy Dhingra, Ravi Runo, James Chybowski, Amy Kozitza, Callyn Batra, Supria Horn, Evelyn M. Chesler, Naomi Eldridge, Marlowe Clin Cardiol Clinical Investigations BACKGROUND: Among subjects with exercise intolerance and suspected early‐stage pulmonary hypertension (PH), early identification of pulmonary vascular disease (PVD) with noninvasive methods is essential for prompt PH management. HYPOTHESIS: Rest gas exchange parameters (minute ventilation to carbon dioxide production ratio: V (E)/VCO(2) and end‐tidal carbon dioxide: ETCO(2)) can identify PVD in early‐stage PH. METHODS: We conducted a retrospective review of 55 subjects with early‐stage PH (per echocardiogram), undergoing invasive exercise hemodynamics with cardiopulmonary exercise test to distinguish exercise intolerance mechanisms. Based on the rest and exercise hemodynamics, three distinct phenotypes were defined: (1) PVD, (2) pulmonary venous hypertension, and (3) noncardiac dyspnea (no rest or exercise PH). For all tests, *p < .05 was considered statistically significant. RESULTS: The mean age was 63.3 ± 13.4 years (53% female). In the overall cohort, higher rest V (E)/VCO(2) and lower rest ETCO(2) (mm Hg) correlated with high rest and exercise pulmonary vascular resistance (PVR) (r ~ 0.5–0.6*). On receiver‐operating characteristic analysis to predict PVD (vs. non‐PVD) subjects with noninvasive metrics, area under the curve for pulmonary artery systolic pressure (echocardiogram) = 0.53, rest V (E)/VCO(2) = 0.70* and ETCO(2) = 0.73*. Based on this, optimal thresholds of rest V (E)/VCO(2) > 40 mm Hg and rest ETCO(2) < 30 mm Hg were applied to the overall cohort. Subjects with both abnormal gas exchange parameters (n = 12, vs. both normal parameters, n = 19) had an exercise PVR 5.2 ± 2.6* (vs. 1.9 ± 1.2), mPAP/CO slope with exercise 10.2 ± 6.0* (vs. 2.9 ± 2.0), and none included subjects from the noncardiac dyspnea group. CONCLUSIONS: In a broad cohort of subjects with suspected early‐stage PH, referred for invasive exercise testing to distinguish mechanisms of exercise intolerance, rest gas exchange parameters (V (E)/VCO(2) > 40 mm Hg and ETCO(2) < 30 mm Hg) identify PVD. John Wiley and Sons Inc. 2022-04-14 /pmc/articles/PMC9286332/ /pubmed/35419844 http://dx.doi.org/10.1002/clc.23831 Text en © 2022 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Raza, Farhan
Dharmavaram, Naga
Hess, Timothy
Dhingra, Ravi
Runo, James
Chybowski, Amy
Kozitza, Callyn
Batra, Supria
Horn, Evelyn M.
Chesler, Naomi
Eldridge, Marlowe
Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title_full Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title_fullStr Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title_full_unstemmed Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title_short Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V (E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
title_sort distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: rest v (e)/vco(2) and etco(2) identify pulmonary vascular disease
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286332/
https://www.ncbi.nlm.nih.gov/pubmed/35419844
http://dx.doi.org/10.1002/clc.23831
work_keys_str_mv AT razafarhan distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT dharmavaramnaga distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT hesstimothy distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT dhingraravi distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT runojames distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT chybowskiamy distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT kozitzacallyn distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT batrasupria distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT hornevelynm distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT cheslernaomi distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease
AT eldridgemarlowe distinguishingexerciseintoleranceinearlystagepulmonaryhypertensionwithinvasiveexercisehemodynamicsrestvevco2andetco2identifypulmonaryvasculardisease